ARCHIVES

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

ORI Bars Cleveland Researcher From Federal Funding

March 24, 1995

Abeloff Plans To Step Down As Cancer Center Director at Hopkins.

November 10, 2006

IG Report Clears Shubik Of Conflict Of Interest Change

October 6, 1978

Children With Recurrent Hodgkin’s Respond To Gemcitabine, Vinorelbine

March 27, 2009

In Brief: Auto Workers Not At Increased risk Of Bladder Cancer, But Truck Drivers Are, New Study Shows

March 11, 1983

Freireich, Moertel Matched Up Again

February 20, 1981